Entheon Biomedical Corp.
ENTBF
$0.069
-$0.0114-14.18%
OTC PK
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -53.12% | 67.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -53.12% | 67.95% | |||
| Operating Income | 53.12% | -67.95% | |||
| Income Before Tax | 53.49% | -67.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 53.49% | -67.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 53.49% | -67.00% | |||
| EBIT | 53.12% | -67.95% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 60.00% | -23.19% | |||
| Normalized Basic EPS | 60.38% | -23.26% | |||
| EPS Diluted | 60.00% | -23.19% | |||
| Normalized Diluted EPS | 60.38% | -23.26% | |||
| Average Basic Shares Outstanding | 15.24% | 35.87% | |||
| Average Diluted Shares Outstanding | 15.24% | 35.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||